LT3219316T - Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui - Google Patents

Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui

Info

Publication number
LT3219316T
LT3219316T LTEP17169929.1T LT17169929T LT3219316T LT 3219316 T LT3219316 T LT 3219316T LT 17169929 T LT17169929 T LT 17169929T LT 3219316 T LT3219316 T LT 3219316T
Authority
LT
Lithuania
Prior art keywords
fatty acids
mixture
treatment
inflammatory pathologies
group
Prior art date
Application number
LTEP17169929.1T
Other languages
English (en)
Inventor
Lodovico BURATTIN
Original Assignee
Again Life Italia Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48227394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3219316(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Again Life Italia Srl filed Critical Again Life Italia Srl
Publication of LT3219316T publication Critical patent/LT3219316T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LTEP17169929.1T 2013-03-08 2014-03-04 Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui LT3219316T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361774796P 2013-03-08 2013-03-08
IT000354A ITMI20130354A1 (it) 2013-03-08 2013-03-08 Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Publications (1)

Publication Number Publication Date
LT3219316T true LT3219316T (lt) 2020-04-10

Family

ID=48227394

Family Applications (2)

Application Number Title Priority Date Filing Date
LT14708015T LT2964215T (lt) 2013-03-08 2014-03-04 Riebalų rūgščių mišinys, skirtas naudoti uždegiminių patologijų gydymui
LTEP17169929.1T LT3219316T (lt) 2013-03-08 2014-03-04 Riebalų rūgščių mišinys (r.r.g., riebalų rūgščių grupė), skirtas naudoti uždegiminių patologijų gydymui

Family Applications Before (1)

Application Number Title Priority Date Filing Date
LT14708015T LT2964215T (lt) 2013-03-08 2014-03-04 Riebalų rūgščių mišinys, skirtas naudoti uždegiminių patologijų gydymui

Country Status (18)

Country Link
US (2) US11020365B2 (lt)
EP (2) EP3219316B1 (lt)
AU (2) AU2014224710B2 (lt)
CA (1) CA2904112C (lt)
CY (2) CY1122248T1 (lt)
DK (2) DK3219316T3 (lt)
EA (2) EA035091B1 (lt)
ES (2) ES2779851T3 (lt)
HK (1) HK1243924A1 (lt)
HR (2) HRP20191963T1 (lt)
HU (2) HUE046239T2 (lt)
IT (1) ITMI20130354A1 (lt)
LT (2) LT2964215T (lt)
PL (2) PL3219316T3 (lt)
PT (2) PT3219316T (lt)
RS (2) RS59523B1 (lt)
SI (2) SI2964215T1 (lt)
WO (1) WO2014135529A1 (lt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.
US9962355B2 (en) 2014-08-08 2018-05-08 Raffaele Migliaccio Mixture of fatty acids and palmitoylethanolamide for use in the treatment of inflammatory and allergic pathologies
AR102008A1 (es) * 2015-09-24 2017-01-25 Brix S R L Ingrediente farmacéutico activo (ifa) oleoso para el tratamiento de afecciones de la piel, composiciones que lo comprenden y su uso para prepararlas
US20210205253A1 (en) * 2018-05-31 2021-07-08 The Asan Foundation Use Of Stearic Acid For Preventing Or Treating Pulmonary Fibrosis
KR102204097B1 (ko) * 2019-01-31 2021-01-18 동신대학교 산학협력단 지방산을 유효성분으로 포함하는 천식 예방 또는 치료용 조성물
CN116472023A (zh) * 2020-02-12 2023-07-21 拜奥吉瓦有限责任公司 用于化妆品应用的氘代多不饱和脂肪酸或其酯
AU2022328181A1 (en) * 2021-08-09 2024-03-21 Kentucky Equine Research, Inc. Compositions and methods for modulating equine fatty acid profiles
WO2023097296A1 (en) * 2021-11-24 2023-06-01 Jenivision Inc. Delivery methods for treating brain and central nervous system diseases

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY24246A1 (es) 1995-06-06 1996-06-14 Neutrogena Corp Vehiculos tropicos que contienen acido azelaico solubilizado y estabilizado
GB9923738D0 (en) 1999-10-07 1999-12-08 Nestle Sa Nutritional composition
DE10161729A1 (de) 2001-12-15 2003-06-18 Mira Ursic Medizinische bzw. pharmazeutische Salbenzubereitung
DE50211883D1 (de) 2002-04-30 2008-04-24 Cognis Ip Man Gmbh Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel
JP2006520803A (ja) * 2003-03-20 2006-09-14 イマジェネティックス, インコーポレイテッド エステル化脂肪酸組成物
US20080057552A1 (en) * 2006-08-31 2008-03-06 Inmok Lee Processes for Producing Fats or Oils and Compositions Comprising the Fats or Oils
NZ552238A (en) 2006-12-20 2009-07-31 Seperex Nutritionals Ltd An extract
JP4512881B2 (ja) * 2007-11-27 2010-07-28 築 中島 薬用油脂
US8765661B2 (en) * 2008-03-20 2014-07-01 Virun, Inc. Compositions containing non-polar compounds
US20090264520A1 (en) 2008-04-21 2009-10-22 Asha Lipid Sciences, Inc. Lipid-containing compositions and methods of use thereof
DK2349250T3 (en) * 2008-10-31 2017-07-03 Lipid Pharmaceuticals Ehf Fatty acids for use as a medicament
BRPI0924012A2 (pt) 2009-04-17 2019-09-24 Cela Vista Pharmaceuticals Ltd processo para obtenção de uma composição rica em ácidos graxos ômega 3 de um óleo de origem marinha, com um teor de af interior 90 mg/g composição, suplemento nutricional produto alimentar, composição farmacêutica, e, uso de um composto
PL2796129T3 (pl) 2009-09-07 2015-11-30 Epitech Group S P A Kompozycja zawierająca palmitoiloetanoloamid poddany ultramikronizacji
CA2703532C (en) 2010-05-10 2018-05-01 Eva Turley Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
DE102010021671A1 (de) 2010-05-27 2011-12-01 Intendis Gmbh Azelainsäurehaltige Formulierung mit Pigmentzusatz
SI2661266T1 (sl) 2011-01-07 2021-01-29 Anji Pharma (Us) Llc Terapije, na osnovi kemosenzoričnih receptorskih ligandov
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
ITMI20130354A1 (it) 2013-03-08 2014-09-09 Again Life Italia Srl Miscela di acidi grassi (f.a.g. fatty acids group) per uso nel trattamento di patologie infiammatorie.

Also Published As

Publication number Publication date
EA035091B1 (ru) 2020-04-27
RS59523B1 (sr) 2019-12-31
AU2014224710A1 (en) 2015-09-10
LT2964215T (lt) 2019-11-25
US20210290578A1 (en) 2021-09-23
SI2964215T1 (sl) 2019-12-31
HRP20200394T1 (hr) 2020-06-12
EP2964215A1 (en) 2016-01-13
ITMI20130354A1 (it) 2014-09-09
HK1243924A1 (zh) 2018-07-27
HUE048361T2 (hu) 2020-08-28
ES2753257T3 (es) 2020-04-07
HUE046239T2 (hu) 2020-02-28
EP3219316B1 (en) 2020-02-19
CY1122783T1 (el) 2021-05-05
EA201791885A1 (ru) 2018-01-31
AU2014224710B2 (en) 2018-04-12
DK3219316T3 (da) 2020-03-16
AU2018202190A1 (en) 2018-04-26
US20160015666A1 (en) 2016-01-21
EA036724B1 (ru) 2020-12-11
DK2964215T3 (da) 2019-11-11
RS60023B1 (sr) 2020-04-30
CY1122248T1 (el) 2020-11-25
US11020365B2 (en) 2021-06-01
PL2964215T3 (pl) 2020-03-31
PT2964215T (pt) 2019-11-12
EP3219316A1 (en) 2017-09-20
CA2904112A1 (en) 2014-09-12
ES2779851T3 (es) 2020-08-20
WO2014135529A1 (en) 2014-09-12
EP2964215B1 (en) 2019-08-21
CA2904112C (en) 2021-03-23
PL3219316T3 (pl) 2020-06-01
HRP20191963T1 (hr) 2020-01-24
SI3219316T1 (sl) 2020-07-31
PT3219316T (pt) 2020-03-27
EA201591680A1 (ru) 2015-12-30
AU2018202190B2 (en) 2019-05-02

Similar Documents

Publication Publication Date Title
HK1243924A1 (zh) 用於治療炎症病理的脂肪酸(f.a.g.,脂肪酸族)混合物
PL2984076T3 (pl) Estry i etery 2,5-tetrahydrofuranu jako plastyfikatory
PL3139770T3 (pl) Kompozycja kwasów tłuszczowych, sposób jej wytwarzania i jej zastosowanie
HRP20181122T1 (hr) Postupak za pripremu jopamidola
IL244755A0 (en) process to create xanthohumol
IL294422B2 (en) Cetylated fatty acids, a system for their preparation and use
HUE040536T2 (hu) Eljárás halogén-N,N-dimetilbenzilaminok elõállítására
EP3093285A4 (en) Gadolinium complex comprising do3a-tranexamic acid conjugate
Mighton For the love of math
SG11201608898UA (en) Unsaturated fatty acid absorption accelerator
PL3083976T3 (pl) Sposób przygotowania tiacumycyny b
GB201316635D0 (en) Masterhitch hooker quick hitch
GB201310891D0 (en) The Universal Alchemical Egg